spacer
home > ict > autumn 2016 > future vision
PUBLICATIONS
International Clinical Trials

Future Vision

Over the past few years, certain factors have contributed to a rising trend of trial supply sourcing: an increase of studies being conducted, reduced start-up timelines, patient recruitment issues, globalisation and the escalating costs for investigational drugs and comparators. Is it even possible to predict the precise number of supplies needed to run a trial efficiently?

Looking Ahead


One option may be the use of forecasting and simulations. Consider a weather forecast, for instance: weathermen will predict high and low temperatures, humidity level, air pressure and other elements based on a number of factors. Different weather models will generally produce similar – but not identical – predictions, shown by minor variations in forecasts from different weather stations. Also, as you look further into the future, the predictions of each model will vary more and reliability will be reduced. This is why, if you are anticipating an event, it is necessary to check weather forecasts regularly as the day of the event approaches.

This is also the case with trial supply forecasts. Forecasting refers to techniques used to predict future outcomes, on the basis of past events and professional insights gained from observation. Methods usually rely on mathematical formulas based on facts, perceived trends, data models and, at times, expert opinions. While it is impossible to know the results of a clinical trial ahead of time with absolute certainty, forecasting provides sponsors with data-driven decisions when planning, running and closing a study.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Praveen Chand is the Director of Professional Services and Clinical Analytics at Cenduit. He brings over 15 years of technology consulting and innovations experience, with a primary focus on pharma and life sciences translational research in clinical trials and drug development. Praveen holds an MS in Computer Science and Engineering, and a BS in Electronics and Instrumentation from GJ University of Science and Technology in Hisar, India.
spacer
Praveen Chand
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals initiates partnership with American Biotech Zhittya for Parkinson’s disease treatment

3P and Zhittya began their relationship at the beginning of 2019 with 3P being selected as the CDMO to transfer the process for scaling up and performing cGMP manufacturing for clinical studies. After successfully achieving transfer of the process, 3P anticipates manufacturing of the first cGMP batch by the second quarter of 2020.
More info >>

White Papers

Wrap Around Label - A Lot of Content in a Small Space

Faubel & Co. Nachfolger GmbH

One of the world’s largest contract research organizations for the planning and conducting of clinical trials was faced with the challenge of accommodating many different national languages on an inhaler. The inhaler was then to be distributed in 47 countries. Due to the impressive quality and reliable collaboration, the organization commissioned Faubel with finding the optimal labeling solution for the inhaler.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement